The synergistic effect of combined ALK and polyamine transport inhibitors suggests that ALK-driven NB cells are highly sensitive to dual inhibition of polyamine metabolism and ALK, with the novel ALK/MARCH11/SLC3A2 regulatory module identified here ultimately regulating polyamine transport and supporting oncogenic growth downstream of ALK in NB cells. Here, SLC3A2 is linked to neuroblastoma.